Transforming R&D Documentation Through Digitization & EffiDocX for Amneal Pharmaceuticals

Published

04 March, 2026

BACKGROUND

Amneal is a global pharmaceutical company focused on high‑quality, affordable medicines, supported by extensive R&D and manufacturing operations across multiple countries with over 8100+ employees.

BUSINESS CHALLENGE

Amneal’s R&D, QA, DQA, and HR departments manage massive volumes of regulated documentation. Their challenges included:

  • Regulatory pressure during US‑FDA audits – Quick document retrieval was essential but difficult with paper‑based systems.
  • Exponential document growth – Manual workflows created delays, risk of misplacement, and lack of traceability.
  • Fragmented, paper‑heavy processes – Departments operated in silos, slowing internal reviews, compliance checks, and submissions.

Amneal needed a secure, centralized, scalable digital repository aligned with global pharmaceutical compliance standards.

CROWN’S ENGAGEMENT & SOLUTION

Crown Information Management partnered with Amneal to deliver a comprehensive Digitisation + EffiDocX (Document Management Solution)

Crown’s Role

Crown acted as Amneal’s digitisation partner and information management specialist, responsible for securely converting paper‑based R&D and QA documentation into structured, searchable digital records and deploying EffiDocX.

Services Delivered

Crown's Engagement & Solution

EXECUTION HIGHLIGHTS

– A trained Crown digitisation team operated entirely on‑site due to the sensitive nature of pharmaceutical documentation.
– A controlled workflow was followed: Collection → Scanning → Indexing → QC → Upload to EffiDocX
– Crown worked department‑wise to avoid disruption to ongoing R&D activities.
– Additional manpower was deployed during peak loads to meet aggressive turnaround timelines.

SPECIAL REQUIREMENTS MET

21 rounds of legal review and a rigorous cybersecurity audit were successfully completed.
– Data handling protocols were aligned with US‑FDA, MHRA, and internal QA compliance norms.
Confidentiality requirements were maintained through secure on‑site processes.
– Compliance with global security and ISO standards
Additional workforce deployed during high-volume cycles
User training & structured onboarding to EffiDocX.

RESULTS & IMPACT

Crown delivered measurable transformation across Amneal’s R&D documentation ecosystem:

Results & Impact

WHY AMNEAL CHOOSE CROWN?

– Global leaders in records & information management
– Proven experience with pharmaceutical compliance
– Strong relationship built since 2022
– Trusted cybersecurity, data governance, and ISO-aligned processes
– Capable of scaling across Amneal’s US facilities

Share this article